{"matchedTerms": [], "ambiguousTerms": [{"searchTerm": "2321", "geneName": "FLT1", "geneLongName": "FMS RELATED TYROSINE KINASE 1", "entrezId": 2321, "geneCategories": [{"id": "4c14ec3171544bd2b18b2f1a45e6c8f2", "name": "KINASE"}, {"id": "6c528ef943614261afc5e4f52a3c60ee", "name": "TYROSINE KINASE"}, {"id": "d3ec2631e0b2434b9dcc008e793d3fa5", "name": "DRUGGABLE GENOME"}, {"id": "0d157beb-fd17-404d-8755-3a81aa5ed704", "name": "CLINICALLY ACTIONABLE"}], "interactions": [{"interactionId": "139ed1d8-dee5-4108-8c4b-92c0f4b1f8cd", "interactionTypes": [], "drugName": "GW843682X", "drugConceptId": "chembl:CHEMBL514499", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "64060319-b76e-40fc-ae91-fc2636091b0e", "interactionTypes": ["inhibitor"], "drugName": "VANDETANIB", "drugConceptId": "chembl:CHEMBL24828", "sources": ["DTC", "TdgClinicalTrial", "ClearityFoundationClinicalTrial", "ChemblInteractions", "MyCancerGenomeClinicalTrial"], "pmids": [], "score": 0.07}, {"interactionId": "f19a0d8c-6329-47d2-9aeb-e8eca198abfa", "interactionTypes": ["inhibitor"], "drugName": "FRUQUINTINIB", "drugConceptId": "chembl:CHEMBL3545339", "sources": ["TdgClinicalTrial", "ChemblInteractions", "TTD"], "pmids": [], "score": 0.77}, {"interactionId": "38bf7093-b97d-439f-9477-c4e7518db367", "interactionTypes": ["inhibitor"], "drugName": "SURUFATINIB", "drugConceptId": "chembl:CHEMBL4297190", "sources": ["ChemblInteractions", "TTD"], "pmids": [], "score": 0.31}, {"interactionId": "4a5fea6a-ea18-4754-880b-29b1e28a8dd8", "interactionTypes": [], "drugName": "KENPAULLONE", "drugConceptId": "chembl:CHEMBL296586", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "87262393-ef49-4917-83d0-9b80f6f85713", "interactionTypes": [], "drugName": "OSI-632", "drugConceptId": "chembl:CHEMBL253969", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "5d656c98-df48-43ca-960e-2be55a471b81", "interactionTypes": [], "drugName": "SP-600125", "drugConceptId": "chembl:CHEMBL1725279", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "d4607e0d-d2a7-4b4d-9869-4dfdb33bf4cd", "interactionTypes": ["inhibitor"], "drugName": "CEDIRANIB", "drugConceptId": "chembl:CHEMBL491473", "sources": ["TALC", "DTC", "TdgClinicalTrial", "ClearityFoundationClinicalTrial", "ChemblInteractions", "CancerCommons"], "pmids": [], "score": 0.1}, {"interactionId": "df5235f2-67dd-4e10-9296-8d6b59407668", "interactionTypes": [], "drugName": "MUPARFOSTAT", "drugConceptId": "chembl:CHEMBL4297163", "sources": ["TdgClinicalTrial"], "pmids": [], "score": 0.08}, {"interactionId": "b178a1c2-3338-4067-b6a0-5439560d26f7", "interactionTypes": ["inhibitor"], "drugName": "AXITINIB", "drugConceptId": "chembl:CHEMBL1289926", "sources": ["TALC", "MyCancerGenome", "TdgClinicalTrial", "ChemblInteractions", "CancerCommons", "MyCancerGenomeClinicalTrial", "PharmGKB"], "pmids": [20124951, 18541897], "score": 0.58}, {"interactionId": "2b57a182-d000-4f7f-87bb-59886ee60f4f", "interactionTypes": ["inhibitor"], "drugName": "CEP-5214", "drugConceptId": "chembl:CHEMBL150894", "sources": ["DTC", "ChemblInteractions"], "pmids": [14640546], "score": 0.77}, {"interactionId": "63126e54-6759-4b7a-adc5-47266345ffde", "interactionTypes": ["inhibitor"], "drugName": "ORANTINIB", "drugConceptId": "chembl:CHEMBL274654", "sources": ["MyCancerGenome"], "pmids": [], "score": 0.09}, {"interactionId": "662d1bc3-3ed0-484c-84ce-d05ea1898d9b", "interactionTypes": ["inhibitor"], "drugName": "4SC-203", "drugConceptId": "chembl:CHEMBL3545358", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.19}, {"interactionId": "1376c04a-64c7-4868-ad7d-1cc38be683f7", "interactionTypes": ["inhibitor"], "drugName": "MOTESANIB", "drugConceptId": "chembl:CHEMBL572881", "sources": ["TALC", "MyCancerGenome", "TdgClinicalTrial", "ChemblInteractions", "PharmGKB"], "pmids": [20124951], "score": 0.58}, {"interactionId": "d31d20fa-7211-4b58-98cb-9ab4b041cf61", "interactionTypes": ["inhibitor"], "drugName": "FAMITINIB", "drugConceptId": "chembl:CHEMBL3545026", "sources": ["ChemblInteractions", "TTD"], "pmids": [], "score": 0.22}, {"interactionId": "b810ae41-bd75-4353-be97-3ed88c98e0eb", "interactionTypes": ["inhibitor"], "drugName": "BMS-690514", "drugConceptId": "chembl:CHEMBL3545396", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.11}, {"interactionId": "0717b137-263f-4e35-814a-28a9458c23dd", "interactionTypes": ["antagonist"], "drugName": "ICRUCUMAB", "drugConceptId": "chembl:CHEMBL1743030", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.77}, {"interactionId": "f85f2a3d-8078-4eac-b8b2-25d422603158", "interactionTypes": ["inhibitor"], "drugName": "ILORASERTIB", "drugConceptId": "chembl:CHEMBL1980297", "sources": ["DTC", "ChemblInteractions"], "pmids": [], "score": 0.01}, {"interactionId": "00823e3a-4fc1-46fb-b1bb-afa1fdbd137b", "interactionTypes": ["inhibitor"], "drugName": "RG-1530", "drugConceptId": "chembl:CHEMBL1980391", "sources": ["DTC", "ChemblInteractions"], "pmids": [], "score": 0.02}, {"interactionId": "d5edd072-139d-4963-8047-80fad4b1921a", "interactionTypes": [], "drugName": "CHEMBL1997335", "drugConceptId": "chembl:CHEMBL1997335", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "e1310ad1-4db4-4b4e-944f-0e751cc8560e", "interactionTypes": ["inhibitor"], "drugName": "ENMD-2076", "drugConceptId": "chembl:CHEMBL482968", "sources": ["MyCancerGenome"], "pmids": [], "score": 0.03}, {"interactionId": "99a64860-5145-406b-b216-5aabdb99c963", "interactionTypes": [], "drugName": "PF-00562271", "drugConceptId": "chembl:CHEMBL1084546", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "04912460-747c-424f-8dbb-5df69c4caf18", "interactionTypes": ["inhibitor"], "drugName": "XL-999", "drugConceptId": "chembl:CHEMBL3545285", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.07}, {"interactionId": "b8e5098d-4915-4c3f-974a-8a0cf9b97bd6", "interactionTypes": ["inhibitor"], "drugName": "TIVOZANIB", "drugConceptId": "chembl:CHEMBL1289494", "sources": ["TALC", "MyCancerGenome", "TdgClinicalTrial", "ClearityFoundationClinicalTrial", "ChemblInteractions", "TTD"], "pmids": [], "score": 0.77}, {"interactionId": "69d955a1-e0ca-4ab1-97c2-c85584b39c14", "interactionTypes": ["inhibitor"], "drugName": "GLESATINIB", "drugConceptId": "chembl:CHEMBL3989914", "sources": ["TALC", "MyCancerGenome", "TdgClinicalTrial"], "pmids": [], "score": 0.29}, {"interactionId": "83ec3190-6362-4197-bbe7-b2f79d8932d4", "interactionTypes": ["inhibitor"], "drugName": "CEP-11981", "drugConceptId": "chembl:CHEMBL2010872", "sources": ["ChemblInteractions", "TTD"], "pmids": [], "score": 0.14}, {"interactionId": "0fb1d292-c673-46dc-aac8-351af8c20c18", "interactionTypes": ["inhibitor"], "drugName": "PAZOPANIB HYDROCHLORIDE", "drugConceptId": "chembl:CHEMBL1201733", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.07}, {"interactionId": "76ad06f4-bea1-4aec-8d3e-4e97ec3e604a", "interactionTypes": [], "drugName": "DORAMAPIMOD", "drugConceptId": "chembl:CHEMBL103667", "sources": ["DTC"], "pmids": [], "score": 0.04}, {"interactionId": "2a6ef284-c9f5-411a-b3c0-5176e2589d71", "interactionTypes": ["inhibitor"], "drugName": "TAK-593", "drugConceptId": "chembl:CHEMBL2180604", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.15}, {"interactionId": "8d5447ca-02c1-4cad-8f30-91d021a830ee", "interactionTypes": [], "drugName": "VEGFRECINE", "drugConceptId": "chembl:CHEMBL2332119", "sources": ["DTC"], "pmids": [], "score": 0.77}, {"interactionId": "a151ece7-551a-4123-a6f5-e40b89641618", "interactionTypes": [], "drugName": "GO-6976", "drugConceptId": "chembl:CHEMBL302449", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "a291af60-2a02-488a-bd94-1a22b73e07eb", "interactionTypes": [], "drugName": "CENISERTIB", "drugConceptId": "chembl:CHEMBL1967878", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "899b5213-83c4-42dc-8bd6-4806aa0309e1", "interactionTypes": ["inhibitor"], "drugName": "SUNITINIB MALATE", "drugConceptId": "chembl:CHEMBL1567", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.09}, {"interactionId": "a94148f1-95d5-407b-9095-255e53d93ccb", "interactionTypes": [], "drugName": "AST-487", "drugConceptId": "chembl:CHEMBL574738", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "33174e1e-b61f-4a1d-bf77-59e4971db5e5", "interactionTypes": ["inhibitor"], "drugName": "BRIVANIB", "drugConceptId": "chembl:CHEMBL377300", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.07}, {"interactionId": "20e0869e-77fc-46e5-9def-849aa54c7c7c", "interactionTypes": ["inhibitor"], "drugName": "BRIVANIB ALANINATE", "drugConceptId": "chembl:CHEMBL270995", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.11}, {"interactionId": "c9937f08-1dda-4750-bdcc-50f55e266888", "interactionTypes": ["inhibitor"], "drugName": "VATALANIB", "drugConceptId": "chembl:CHEMBL101253", "sources": ["TALC", "DTC", "MyCancerGenome", "TdgClinicalTrial", "ChemblInteractions"], "pmids": [17584317], "score": 0.36}, {"interactionId": "d66e07b9-e934-4b64-b144-7764a5016f82", "interactionTypes": ["inhibitor"], "drugName": "CHIAURANIB", "drugConceptId": "chembl:CHEMBL3545428", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.19}, {"interactionId": "fc3da3d5-9d32-4100-ba4d-54f99e31ca11", "interactionTypes": ["inhibitor"], "drugName": "CP-459632", "drugConceptId": "chembl:CHEMBL3545300", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.1}, {"interactionId": "f65bafe3-3802-497a-83d1-e8793fbb6240", "interactionTypes": [], "drugName": "TELATINIB", "drugConceptId": "chembl:CHEMBL2079588", "sources": ["TdgClinicalTrial"], "pmids": [], "score": 0.13}, {"interactionId": "88002b9c-a489-4c14-96a0-9e3abb97f3fc", "interactionTypes": ["inhibitor"], "drugName": "SEMAXANIB", "drugConceptId": "chembl:CHEMBL276711", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.06}, {"interactionId": "91213770-279a-4920-87eb-7ddb0007c8f2", "interactionTypes": [], "drugName": "ALISERTIB", "drugConceptId": "chembl:CHEMBL483158", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "1b7b892b-04b2-4fe4-8778-a91d38110012", "interactionTypes": [], "drugName": "TOZASERTIB", "drugConceptId": "chembl:CHEMBL572878", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "15d07a17-335c-4749-832d-9963624e4b32", "interactionTypes": ["inhibitor"], "drugName": "OSI-930", "drugConceptId": "chembl:CHEMBL1614710", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.15}, {"interactionId": "70b41f85-6e3f-4ca4-9402-3206e5f8910d", "interactionTypes": ["inhibitor"], "drugName": "XL-820", "drugConceptId": "chembl:CHEMBL3545402", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.13}, {"interactionId": "9bc54be2-f5d3-4da2-953b-f0c2960d9806", "interactionTypes": ["inhibitor"], "drugName": "X-82", "drugConceptId": "chembl:CHEMBL3545401", "sources": ["MyCancerGenome", "ChemblInteractions", "TTD"], "pmids": [], "score": 0.46}, {"interactionId": "a931fd93-b4ae-418c-ad74-bb215e473047", "interactionTypes": ["inhibitor"], "drugName": "NINTEDANIB", "drugConceptId": "chembl:CHEMBL502835", "sources": ["TALC", "MyCancerGenome", "TdgClinicalTrial", "ClearityFoundationClinicalTrial"], "pmids": [18559524, 31016670], "score": 0.22}, {"interactionId": "0ee7c9ab-233b-4cdc-9a1b-8534b1f21444", "interactionTypes": ["inhibitor"], "drugName": "LUCITANIB", "drugConceptId": "chembl:CHEMBL2220486", "sources": ["ChemblInteractions", "MyCancerGenomeClinicalTrial"], "pmids": [], "score": 0.26}, {"interactionId": "f5e2643e-a193-432f-abb2-af182b7bd8ed", "interactionTypes": [], "drugName": "TAE-684", "drugConceptId": "chembl:CHEMBL509032", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "877173d2-084e-4c0a-9632-f1804c0ed606", "interactionTypes": [], "drugName": "ABICIPAR PEGOL", "drugConceptId": "chembl:CHEMBL4297684", "sources": ["TdgClinicalTrial"], "pmids": [], "score": 0.26}, {"interactionId": "0a2bcaba-5960-469b-98d7-0bc4a9a52f25", "interactionTypes": [], "drugName": "ERLOTINIB", "drugConceptId": "chembl:CHEMBL553", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "c70bb0c7-8e82-4de5-b051-84bae8f99545", "interactionTypes": [], "drugName": "PD-0166285", "drugConceptId": "chembl:CHEMBL49120", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "aaaa9872-071d-49e5-8b4a-af4bc4b8ecea", "interactionTypes": ["inhibitor"], "drugName": "RABEPRAZOLE SODIUM", "drugConceptId": "chembl:CHEMBL1200930", "sources": ["MyCancerGenome", "TTD"], "pmids": [], "score": 0.09}, {"interactionId": "b0304972-909a-4e89-96d8-1636bad7eae1", "interactionTypes": ["inhibitor"], "drugName": "FORETINIB", "drugConceptId": "chembl:CHEMBL1230609", "sources": ["MyCancerGenome", "ChemblInteractions"], "pmids": [], "score": 0.13}, {"interactionId": "1510896a-5dd8-4f24-90d8-4e9655599aa2", "interactionTypes": ["inhibitor"], "drugName": "SORAFENIB TOSYLATE", "drugConceptId": "chembl:CHEMBL1200485", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.05}, {"interactionId": "dfef055f-d6a9-4bdf-9bb0-4458947a11b3", "interactionTypes": ["inhibitor"], "drugName": "SU-014813", "drugConceptId": "chembl:CHEMBL1721885", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.11}, {"interactionId": "e6d3f100-d254-436d-aced-0e52e86dca74", "interactionTypes": [], "drugName": "ENTRECTINIB", "drugConceptId": "chembl:CHEMBL1983268", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "8d8db122-e4f5-42e7-a3e1-8cc0aacbe48b", "interactionTypes": ["inhibitor"], "drugName": "LENVATINIB", "drugConceptId": "chembl:CHEMBL1289601", "sources": ["TALC", "TdgClinicalTrial"], "pmids": [17943726], "score": 0.19}, {"interactionId": "e26d7cb9-110d-4cb6-8deb-6492492b9f05", "interactionTypes": ["inhibitor"], "drugName": "L-21649", "drugConceptId": "chembl:CHEMBL3544927", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.26}, {"interactionId": "d7a01e79-5b44-43c8-ba23-4b1093e6734e", "interactionTypes": [], "drugName": "JNJ-7706621", "drugConceptId": "chembl:CHEMBL191003", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "a0727ff9-3976-44fc-851b-0ab1b901f726", "interactionTypes": ["inhibitor"], "drugName": "CEP-7055", "drugConceptId": "chembl:CHEMBL346631", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.26}, {"interactionId": "ac6e0afc-316d-4f8e-9ce7-e96e70658d86", "interactionTypes": ["inhibitor"], "drugName": "AG-13958", "drugConceptId": "chembl:CHEMBL3545335", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.26}, {"interactionId": "31341929-9e60-4379-af30-9e6f69dd0912", "interactionTypes": ["inhibitor"], "drugName": "PAZOPANIB", "drugConceptId": "chembl:CHEMBL477772", "sources": ["TALC", "DTC", "MyCancerGenome", "TdgClinicalTrial", "MyCancerGenomeClinicalTrial"], "pmids": [17288876], "score": 0.11}, {"interactionId": "3f65174e-1af4-4c38-8b54-d34af3de33fa", "interactionTypes": ["inhibitor"], "drugName": "TG100-801", "drugConceptId": "chembl:CHEMBL403989", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.05}, {"interactionId": "cdd025e6-182b-4095-86a3-12a5bad752f7", "interactionTypes": ["inhibitor"], "drugName": "REGORAFENIB", "drugConceptId": "chembl:CHEMBL1946170", "sources": ["TALC", "MyCancerGenome", "ChemblInteractions", "MyCancerGenomeClinicalTrial"], "pmids": [], "score": 0.11}, {"interactionId": "bf64a7b2-4698-4af5-b9fd-4d1885874818", "interactionTypes": ["inhibitor"], "drugName": "KRN-633", "drugConceptId": "chembl:CHEMBL406381", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.26}, {"interactionId": "d7a3395d-b1d5-43d9-a65b-f0438264229f", "interactionTypes": ["agonist"], "drugName": "TELBERMIN", "drugConceptId": "chembl:CHEMBL2108557", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.39}, {"interactionId": "be814a9c-d5d2-49c0-8b4b-6a579c549ccf", "interactionTypes": ["inhibitor"], "drugName": "LENVATINIB MESYLATE", "drugConceptId": "chembl:CHEMBL2105704", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.26}, {"interactionId": "28ee9e1d-4dea-4224-bb10-26177b6faf41", "interactionTypes": ["inhibitor"], "drugName": "TESEVATINIB", "drugConceptId": "chembl:CHEMBL3544983", "sources": ["MyCancerGenome", "TdgClinicalTrial"], "pmids": [], "score": 0.22}, {"interactionId": "072b1016-f38f-4f69-971a-a92ce3f4f981", "interactionTypes": ["inhibitor"], "drugName": "MGCD-265", "drugConceptId": "chembl:CHEMBL254760", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.13}, {"interactionId": "2b174732-d183-41ef-b445-c5ddc3f2d2d7", "interactionTypes": ["inhibitor"], "drugName": "SUNITINIB", "drugConceptId": "chembl:CHEMBL535", "sources": ["TALC", "DTC", "TdgClinicalTrial", "TEND", "MyCancerGenomeClinicalTrial", "PharmGKB"], "pmids": [21478036, 19248971, 26935927, 23583911, 17367763, 20124951, 24086736, 14654525], "score": 0.28}, {"interactionId": "84d29874-3939-4d46-8a13-4237eba8a021", "interactionTypes": ["inhibitor"], "drugName": "AEE-788", "drugConceptId": "chembl:CHEMBL587723", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.13}, {"interactionId": "98d62e4c-a9df-40eb-9566-04ef8f78f24b", "interactionTypes": ["inhibitor"], "drugName": "SORAFENIB", "drugConceptId": "chembl:CHEMBL1336", "sources": ["DTC", "MyCancerGenome", "MyCancerGenomeClinicalTrial", "PharmGKB"], "pmids": [17016424, 28362716, 15466206, 16507829], "score": 0.08}, {"interactionId": "eded1f7a-b3a7-42ee-8bfd-92a9f687e0ba", "interactionTypes": [], "drugName": "R-406", "drugConceptId": "chembl:CHEMBL475251", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "9dd1c6c5-c11b-41a8-b305-4785becc763e", "interactionTypes": ["inhibitor"], "drugName": "NINTEDANIB ESYLATE", "drugConceptId": "chembl:CHEMBL3039504", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.09}, {"interactionId": "740d1c7a-59c9-47ec-a8cd-1c1782c8b64f", "interactionTypes": [], "drugName": "CYC-116", "drugConceptId": "chembl:CHEMBL482967", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "7809eb46-bf5d-4e4e-93f2-6d7246ff5888", "interactionTypes": ["inhibitor"], "drugName": "DOVITINIB", "drugConceptId": "chembl:CHEMBL522892", "sources": ["DTC", "TdgClinicalTrial", "ClearityFoundationClinicalTrial", "ChemblInteractions", "CancerCommons"], "pmids": [], "score": 0.04}, {"interactionId": "60b55149-7397-455b-a044-7116909a378d", "interactionTypes": ["inhibitor"], "drugName": "LINIFANIB", "drugConceptId": "chembl:CHEMBL223360", "sources": ["DTC", "MyCancerGenome", "TdgClinicalTrial", "ChemblInteractions"], "pmids": [], "score": 0.04}, {"interactionId": "d8275be0-4828-4765-a82b-8c0cb23427dd", "interactionTypes": [], "drugName": "PEGPLERANIB SODIUM", "drugConceptId": "chembl:CHEMBL3301576", "sources": ["TdgClinicalTrial"], "pmids": [], "score": 0.13}, {"interactionId": "6ccfa5ec-bf72-47eb-89a0-78114b3ee535", "interactionTypes": [], "drugName": "AZD-1152-HQPA", "drugConceptId": "chembl:CHEMBL215152", "sources": ["DTC"], "pmids": [], "score": 0.04}]}, {"searchTerm": "2321", "geneName": "CPOX", "geneLongName": "COPROPORPHYRINOGEN OXIDASE", "entrezId": 1371, "geneCategories": [{"id": "4866b8ad-3c3e-4c04-802f-587f697212db", "name": "ENZYME"}], "interactions": [{"interactionId": "3121be91-71f1-42c9-987f-71a5e1f28b0e", "interactionTypes": [], "drugName": "GIVOSIRAN", "drugConceptId": "chembl:CHEMBL4297760", "sources": ["PharmGKB", "FDA"], "pmids": [], "score": 41.22}]}], "unmatchedTerms": []}